PF 03814735

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 2023

CAS [942487-16-3]

MF C23H25F3N6O2
MW 474.48

  • Purity: 98%
  • Optical purity: Optically pure
  • Soluble in DMSO

PF 03814735

Description

Potent, orally bioavailable, ATP-competitive and reversible inhibitor of aurora kinase A (IC50: 0.8 nM) and aurora kinase B (IC50: 5 nM) with potential antineoplastic activity; PF 03814735 also inhibits Flt1, FAK and TrkA with IC50 values of 10, 22, 30 nM respectively; clinical candidate.

KEYWORDS: PF 03814735 | supplier | Aurora inhibitor | PF03814735 | PF-03814735 | CAS [942487-16-3] | Histone | Survivin | Topo | TPX2 | Aurora kinase | antineoplastic activity | Flt1 | FAK | TrkA | clinical candidate

Order
Size Unit Price Stock
5 mg €120.00 In Stock
25 mg €420.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €180.00 In Stock
2 x 25 mg €640.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...